IP Library Granted Patent US 7,939,626
Granted Patent B2
US 7,939,626 · App. 11/533,129 · Granted May 10, 2011

Chemoselective ligation

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,626
App. No.
11/533,129
Granted
May 10, 2011
Kind
B2
Abstract

The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).

Claims (17)

1. A compound of the formula:

X 1 —Y—R 4 —PR 2 R 3

where

X 1 is a peptide having a length of from 3 to 150 amino acids;

Y is carbonyl or thiocarbonyl;

R 4 is an alkyl group, a cycloalkyl group, an aryl group, a substituted aryl group; and

R 2 and R 3 are independently aryl groups, substituted aryl groups, or cycloalkyl groups,

or wherein R 4 —PR 2 R 3 is a methylphosphine ester: O—CH 2 —PR 2 R 3 , or S—CH 2 —PR 2 R 3 .

2. The compound of claim 1 , wherein R 4 —PR 2 R 3 is a methylphosphine ester.

3. The compound of claim 1 , wherein R 4 —PR 2 R 3 is

4. The compound of claim 3 , wherein R 4 —PR 2 R 3 is

5. The compound of claim 1 , wherein R 4 —PR 2 R 3 is

6. The compound of claim 5 , wherein R 4 —PR 2 R 3 is

7. The compound of claim 1 , wherein R 4 —PR 2 R 3 is a methyl diphenylphosphine ester.

8. The compound of claim 1 , wherein the peptide has a length of from 3 amino acids to 5 amino acids.

9. The compound of claim 1 , wherein the peptide has a length of from 25 amino acids to 150 amino acids.

10. The compound of claim 1 , wherein the peptide has a length of from 10 amino acids to 50 amino acids.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 28, 2018
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045749/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2007
From: SAXON, ELIANA; BERTOZZI, CAROLYN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 018862/0518 →
Continuity (6)
Division 11408605 · Apr 20, 2006
Division 11039478 · Jan 19, 2005
Division 10384099 · Mar 6, 2003
Division 09810864 · Mar 16, 2001
Provisional Application 60189837 · Mar 16, 2000
Related Publication 20070037964A1 · Feb 15, 2007